Vital Therapies Provides Corporate Update
09 janv. 2017 08h00 HE
|
Vital Therapies, Inc.
SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...